Nu Skin Enterprises EBIT

As of the most recent data (September 2026), NUS shows a EBIT of $-27M. That compares with $-11M in the prior-year period — down 141.1% year over year. That is below the Consumer Discretionary sector average of $3.4T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NUS's EBIT is now $-27M (was $-11M) — a 141.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Nu Skin Enterprises is outperforming or lagging.

The Consumer Discretionary sector average EBIT is about $3.4T. Nu Skin Enterprises is at $-27M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how NUS stacks up against individual peers as well.

Tracking NUS's ebit over time shows whether Nu Skin Enterprises is scaling, shrinking, or reshaping that part of the business. The current reading is $-27M That compares with $-11M in the prior-year period — down 141.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Nu Skin Enterprises's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-27M) with ownership activity and broader fundamentals.